Axonyx Incorporated

AXYX is engaged in the business of identifying and acquiring novel post-discovery central nervous system (CNS) drug candidates to advance through clinical development towards regulatory approval and acquiring patent rights and developing CNS pharmaceutical compounds.

Contact Details: 825 Third Avenue 40th Floor New York NY 10022 United States of America Tel: 212 688 4770 Fax: 212 688 4843 Email: info@axonyx.com WWW: www.axonyx.com/

Loading...

Axonyx Incorporated Patents:
US Patent No.	Title
7153882	Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
6689753	.beta. sheet breaker peptide analogs that inhibit .beta. pleated sheet formation in amyloid .beta.-peptide
6683105	Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias
6495700	Process for producing phenserine and its analog

Axonyx Incorporated (ONXX) Financial information Links from Barchart
ONXX Quote from from Barchart.com
ONXX Chart from from Barchart.com
ONXX Profile from from Barchart.com
ONXX Opinion from from Barchart.com
→View more Axonyx Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 384 times since April 2007, the link to the organisation's website has been followed 99 times

Search for more companies in New York

Search for more companies in NY

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Axonyx Incorporated